全文获取类型
收费全文 | 2391篇 |
免费 | 136篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 75篇 |
儿科学 | 36篇 |
妇产科学 | 44篇 |
基础医学 | 347篇 |
口腔科学 | 186篇 |
临床医学 | 157篇 |
内科学 | 541篇 |
皮肤病学 | 34篇 |
神经病学 | 222篇 |
特种医学 | 37篇 |
外科学 | 207篇 |
综合类 | 2篇 |
预防医学 | 162篇 |
眼科学 | 51篇 |
药学 | 230篇 |
中国医学 | 21篇 |
肿瘤学 | 185篇 |
出版年
2024年 | 5篇 |
2023年 | 22篇 |
2022年 | 60篇 |
2021年 | 93篇 |
2020年 | 47篇 |
2019年 | 72篇 |
2018年 | 101篇 |
2017年 | 55篇 |
2016年 | 73篇 |
2015年 | 78篇 |
2014年 | 145篇 |
2013年 | 179篇 |
2012年 | 219篇 |
2011年 | 238篇 |
2010年 | 89篇 |
2009年 | 91篇 |
2008年 | 167篇 |
2007年 | 145篇 |
2006年 | 145篇 |
2005年 | 107篇 |
2004年 | 101篇 |
2003年 | 81篇 |
2002年 | 55篇 |
2001年 | 13篇 |
2000年 | 19篇 |
1999年 | 8篇 |
1998年 | 8篇 |
1997年 | 4篇 |
1996年 | 6篇 |
1995年 | 8篇 |
1994年 | 6篇 |
1993年 | 3篇 |
1992年 | 14篇 |
1991年 | 11篇 |
1990年 | 11篇 |
1989年 | 4篇 |
1988年 | 12篇 |
1987年 | 4篇 |
1986年 | 8篇 |
1985年 | 7篇 |
1984年 | 4篇 |
1980年 | 2篇 |
1979年 | 3篇 |
1975年 | 3篇 |
1974年 | 2篇 |
1971年 | 1篇 |
1970年 | 1篇 |
1969年 | 3篇 |
1961年 | 1篇 |
1944年 | 1篇 |
排序方式: 共有2537条查询结果,搜索用时 0 毫秒
21.
Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. 总被引:1,自引:0,他引:1
G Grazzini G Castiglione C Ciabattoni F Franceschini D Giorgi S Gozzi P Mantellini P Lopane M Perco T Rubeca P Salvadori C B Visioli M Zappa 《European journal of cancer prevention》2004,13(1):19-26
Screening with faecal occult blood test (FOBT) has been shown to be effective in reducing mortality from colorectal cancer. Tuscany was the first region in Italy in which a screening programme for colorectal cancer by FOBT was initiated region-wide. The aim of the paper was to describe organizational aspects, a quality control model and the results of this experience. From June 2000 to December 2001, 192583 subjects aged 50-70 were invited to undergo a 1-day immunochemical test without any dietary restriction. A total of 78505 subjects (41%) performed the screening test, of whom 4537 responders had a positive test result (5.8%). Among them, 1122 refused any form of assessment or underwent a colonoscopy outside the screening referral centres, with an overall assessment compliance of 75.3%. Malignancies were found in 193 patients and at least a high-risk adenomatous polyp in 692 patients. In about a quarter of the positive subjects who underwent assessment, cancer or high-risk adenoma was detected. In conclusion, data from this experience supported the feasibility of biennial colorectal screening programme by FOBT, particularly regarding invitation compliance and positivity rate. Further efforts are necessary to implement screening extension and to improve data collection. 相似文献
22.
We read with great interest the debate on colorectal cancer(CRC) screening in volume 13 issue 1 of the Annals of Oncology[1]. As opinions in the debate are controversial we would liketo contribute to the discussion on the basis of our experience. The criticisms by the majority of the authors involved in thedebate are based on the results of randomised trials that demonstratethe efficacy of guaiac-based faecal occult blood tests (FOBTs).Guaiac testing was the only available method at the time thosetrials started, approximately two decades 相似文献
23.
B. van Wegberg M. Bacchi P. Heusser S. Helwig R. Schaad E. von Rohr J. Bernhard C. Hürny M. Castiglione Th. Cerny 《Annals of oncology》1998,9(10):1091-1096
Questions of meaning and challenge by illness, i.e., the spiritual dimension of quality of life (QL) traditionally played an important role in anthroposophically oriented medicine and have gained importance in palliative medicine and supportive care. In the context of a research project on QL in patients with advanced cancer, we therefore investigated the psychometric properties of a questionnaire covering spiritual QL issues, with the aim of providing a module for the assessment of cognitive-spiritual QL.Patients and methods: We investigated 89 patients with advanced breast and gastro-intestinal cancer. Construct validity of a modified version of the SELT (Skalen zur Erfassung von Lebensqualität bei Tumorkranken), the SELT-M was tested by multitrait scaling analysis. Discriminant and convergent validity were also tested. The EORTC QLQ-C30 was used as a standard for validation.Results showed the SELT-M as feasible in administration. Four of the five SELT-M subscales were internally consistent (Cronbach's Alpha = >0.7). The subscale on spiritual QL showed higher within than outside subscale correlations for six of its eight items. Association of the SELT-M with the EORTC QLQ-C30 was good for the items and subscales covering the same aspects of QL in both questionnaires: emotional (Spearman r = 0.61), physical functioning (r = –0.54) and fatigue (r = –0.75). In accordance with expectations, there was no association between spiritual QL with any EORTC QLQ-C30 subscales. Self-assessed spiritual QL in the SELT-M corresponded well with interviewer assessments (test for trend accross ordered groups, P = 0.0023).Conclusions: Overall there is confirming evidence for the hypothesised structure of the SELT-M, especially for the newly developed module on spiritual QL. This module may be used as a module together with other cancer specific QL questionnaires. 相似文献
24.
Paola Ungaro Immacolata Cristina Nettore Fabiana Franchini Giuseppe Palatucci Giovanna Muscogiuri Annamaria Colao Paolo Emidio Macchia 《Nutrients》2022,14(15)
Ketogenic diets (KD) are dietary strategies low in carbohydrates, normal in protein, and high, normal, or reduced in fat with or without (Very Low-Calories Ketogenic Diet, VLCKD) a reduced caloric intake. KDs have been shown to be useful in the treatment of obesity, metabolic diseases and related disorders, neurological diseases, and various pathological conditions such as cancer, nonalcoholic liver disease, and chronic pain. Several studies have investigated the intracellular metabolic pathways that contribute to the beneficial effects of these diets. Although epigenetic changes are among the most important determinants of an organism’s ability to adapt to environmental changes, data on the epigenetic changes associated with these dietary pathways are still limited. This review provides an overview of the major epigenetic changes associated with KDs. 相似文献
25.
Gustavo Henrique Soares Takano Rivadvio Fernandes Amorim Vnia Moraes Ferreira Leonora Maciel de Souza Vianna Tercia Maria Mendes Lousa de Castro Marcos de Vasconcelos Carneiro Ísis de Araújo Oliveira Andrea Barretto Motoyama Fabiana Pirani Carneiro 《International journal of clinical and experimental pathology》2022,15(4):191
Introduction: In women, most malignant effusions are from breast and ovary primary carcinomas that have metastasized to body cavity fluids (pleural, peritoneal and pericardial). When carcinoma is diagnosed in effusions, it is not possible to identify its site of origin solely by cytology (morphology); therefore, immunocytochemistry is used as a complementary method. There are no immunocytochemical markers with 100% sensitivity and specificity for identifying carcinoma primary site. The markers most used are TTF-1 for the lung, GATA-3 for the breast, and PAX-8 for the ovary. The aim of this study was to evaluate the sensitivity and specificity of a panel including these markers for detecting the primary site of carcinoma in effusions. Methods: Samples of pleural, pericardial, and peritoneal effusions and peritoneal washings with carcinoma of known primary site from women (n = 60) and men (n = 18) were prepared by using the cell block method, and immunocytochemistry was performed to evaluate the expression of primary site markers (TTF-1, PAX-8, and GATA-3). Results: In women, the breast was the most frequent primary site of metastatic carcinoma to both pleural and pericardial cavities, followed by the lung, whereas the ovary was the most frequent primary site of carcinoma within peritoneal effusions and washings, followed by the gastrointestinal tract (stomach or intestine). The expected profiles for carcinomas of the most common primary sites were: breast (GATA-3 (+), PAX-8 (-), TTF-1 (-)), ovary (PAX-8 (+), GATA-3 (-), TTF-1 (-)), lung (TTF-1 (+), PAX-8 (-) GATA-3 (-)) and gastrointestinal tract (PAX-8 (-), GATA-3 (-), TTF-1 (-)). These were observed in 88.23% (45/51) of women’s samples with carcinoma from these primary sites. By using TTF-1 as the sole primary site marker, 6.25% of carcinomas of primary site other than the lung would have been misdiagnosed. Conclusion: An initial panel of markers including GATA-3, PAX-8, and TTF-1 allows, with high sensitivity and specificity, the identification or exclusion of frequent primary sites of carcinoma in effusions from women. Our results highlight the importance of using a panel of markers to avoid misidentification of the primary site of tumor. 相似文献
26.
Vania C. Minguetti-Camara Any de C. R. Marques Fabiana P. M. Schiavon Vanessa R. Vilela Marcos L. Brusch Roberto Barbosa Bazotte 《Nutrients》2014,6(10):4520-4530
We compared the effects of oral administration of high-dose or low-dose glutamine dipeptide (GDP), alanine (ALA), glutamine (GLN), and ALA + GLN on the blood availability of amino acids in rats submitted to insulin-induced hypoglycemia (IIH). Insulin detemir (1 U/kg) was intraperitoneally injected to produce IIH; this was followed by oral administration of GDP, GLN + ALA, GLN, or ALA. We observed higher blood levels of GLN, 30 min after oral administration of high-dose GDP (1000 mg/kg) than after administration of ALA (381 mg/kg) + GLN (619 mg/kg), GLN (619 mg/kg), or ALA (381 mg/kg). However, we did not observe the same differences after oral administration of low-dose GDP (100 mg/kg) compared with ALA (38.1 mg/kg) + GLN (61.9 mg/kg), GLN (61.9 mg/kg), or ALA (38.1 mg/kg). We also observed less liver catabolism of GDP compared to ALA and GLN. In conclusion, high-dose GDP promoted higher blood levels of GLN than oral ALA + GLN, GLN, or ALA. Moreover, the lower levels of liver catabolism of GDP, compared to ALA or GLN, contributed to the superior performance of high-dose GDP in terms of blood availability of GLN. 相似文献
27.
28.
Paola Carpinetti Elisa Donnard Fabiana Bettoni Paula Asprino Fernanda Koyama Andrei Rozanski Jorge Sabbaga Angelita Habr-Gama Raphael B. Parmigiani Pedro A.F. Galante Rodrigo O. Perez Anamaria A. Camargo 《Oncotarget》2015,6(35):38360-38371
Neoadjuvant chemoradiotherapy (nCRT) followed by surgery is the mainstay treatment for locally advanced rectal cancer. Variable degrees of tumor regression are observed after nCRT and alternative treatment strategies, including close surveillance without immediate surgery, have been investigated to spare patients with complete tumor regression from potentially adverse outcomes of radical surgery. However, clinical and radiological assessment of response does not allow accurate identification of patients with complete response. In addition, surveillance for recurrence is similarly important for these patients, as early detection of recurrence allows salvage resections and adjuvant interventions. We report the use of liquid biopsies and personalized biomarkers for monitoring treatment response to nCRT and detecting residual disease and recurrence in patients with rectal cancer. We sequenced the whole-genome of four rectal tumors to identify patient-specific chromosomal rearrangements that were used to monitor circulating tumor DNA (ctDNA) in liquid biopsies collected at diagnosis and during nCRT and follow-up. We compared ctDNA levels to clinical, radiological and pathological response to nCRT. Our results indicate that personalized biomarkers and liquid biopsies may not be sensitive for the detection of microscopic residual disease. However, it can be efficiently used to monitor treatment response to nCRT and detect disease recurrence, preceding increases in CEA levels and radiological diagnosis. Similar good results were observed when assessing tumor response to systemic therapy and disease progression. Our study supports the use of personalized biomarkers and liquid biopsies to tailor the management of rectal cancer patients, however, replication in a larger cohort is necessary to introduce this strategy into clinical practice. 相似文献
29.
Omer Onur Cakir Fabio Castiglione Zafer Tandogdu Justin Collins Hussain M. Alnajjar Clare Akers Maarten Albersen Constantine Alifrangis Benjamin Ayres Oscar Brouwer Ivor Cullen Peter Hawkey Jakob Kristian Jakobsen Truls Erik Bjerklund Johansen Odunayo Kalejaiye Asheesh Kaul Bela Köves Vivekanandan Kumar Asif Muneer 《Urologic oncology》2021,39(3):197.e9-197.e17
ObjectivesTo develop an international consensus on managing penile cancer patients during the COVID-19 acute waves. A major concern for patients with penile cancer during the coronavirus disease 2019 (COVID-19) pandemic is how the enforced safety measures will affect their disease management. Delays in diagnosis and treatment initiation may have an impact on the extent of the primary lesion as well as the cancer-specific survival because of the development and progression of inguinal lymph node metastases.Materials and methodsA review of the COVID-19 literature was conducted in conjunction with analysis of current international guidelines on the management of penile cancer. Results were presented to an international panel of experts on penile cancer and infection control by a virtual accelerated Delphi process using 4 survey rounds. Consensus opinion was defined as an agreement of ≥80%, which was used to reconfigure management pathways for penile cancer.ResultsLimited evidence is available for delaying penile cancer management. The consensus rate of agreement was 100% that penile cancer pathways should be reconfigured, and measures should be developed to prevent perioperative nosocomial transmission of COVID-19. The panel also reached a consensus on several statements aimed at reconfiguring the management of penile cancer patients during the COVID-19 pandemic.ConclusionsThe international consensus panel proposed a framework for the diagnostic and invasive therapeutic procedures for penile cancer within a low-risk environment for COVID-19. 相似文献